Viewing Study NCT04595994


Ignite Creation Date: 2025-12-25 @ 1:59 AM
Ignite Modification Date: 2025-12-26 @ 12:23 AM
Study NCT ID: NCT04595994
Status: RECRUITING
Last Update Posted: 2024-01-23
First Post: 2020-10-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Selinexor Plus Gemcitabine in Selected Advanced Soft-tissue Sarcoma and Osteosarcoma
Sponsor: Grupo Espanol de Investigacion en Sarcomas
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module